Dr Fathi Al-Jehani
Dr Al-Jehani is a Consultant Haematologist with over 16 years of Haemato-oncology experience. He is the clinical lead of the Haematology Department at Croydon University Hospital, London.
Based At
NHS base
Croydon University Hospital
GMC Number
4455965
Clinic Timetable
Clinical interests
He has a specialist interest in haemato-oncology including myeloma; lymphomas and leukaemias. Alongside his clinical work he has also had an active role in teaching doctors in training, held the role of the appraiser and principal investigator of AML19, PETRea, MCL bank and Myeloma FiTness clinical trials at Croydon University Hospital. Dr Al-Jehani's broad training background and current specialised role mean that he can provide the perfect combination of high-level diagnostics and individualised cutting-edge care.
Dr Al-Jehani's main interests are diagnosis and treatment of patients with haematological disorders including:
- Leukaemia
- Lymphoma
- Myeloma
- Myelodysplasia
- Myeloproliferative disorders
He also treats patients with:
- Anaemias
- Polycythaemia
- Low/high white cell and/or platelet counts
- High ferritin
- Lymph gland swelling
He can treat patients with chemotherapy and biological targeted therapies such as antibodies, small molecules (often tablets).
Dr Al-Jehani is happy to provide second opinions if requested. He works with a talented team of clinicians, pathologists and radiologists to provide the very best advice in terms of diagnosis and treatment.
Professional Memberships
MB ChB Al-Arab Medical University Libya 1989
MRCP Royal College of Physicians, London 1994
DIM RPMS University of London, London 1994
MSc in Haematology, University of London, London 1995
FRCPath Royal College of Pathologists, London 2005
CCT Postgraduate Medical Education and Training Board 2006
Academic Background
After completing his training in Medicine in 1989, he started his career in haematology at Hammersmith Hospital. In 1994 he completed his Master's degree from the University of London and attained his Specialist in Haematology status in 2006. In 2014 he was appointed as a Consultant Haematologist at Croydon University Hospital. He is currently the Clinical lead of haematology department and chair for the chemotherapy working group. Alongside his clinical work he has also has an active role in teaching doctors in training, hold appraiser role and priniciple investigator of AML19, PETrea, MCL bank and Myeloma FiTness clinical trials at Croydon University Hospital.
Based at
NHS base
Croydon University Hospital
GMC Number
4455965
Clinic Timetable
Clinical interests
He has a specialist interest in haemato-oncology including myeloma; lymphomas and leukaemias. Alongside his clinical work he has also had an active role in teaching doctors in training, held the role of the appraiser and principal investigator of AML19, PETRea, MCL bank and Myeloma FiTness clinical trials at Croydon University Hospital. Dr Al-Jehani's broad training background and current specialised role mean that he can provide the perfect combination of high-level diagnostics and individualised cutting-edge care.
Dr Al-Jehani's main interests are diagnosis and treatment of patients with haematological disorders including:
- Leukaemia
- Lymphoma
- Myeloma
- Myelodysplasia
- Myeloproliferative disorders
He also treats patients with:
- Anaemias
- Polycythaemia
- Low/high white cell and/or platelet counts
- High ferritin
- Lymph gland swelling
He can treat patients with chemotherapy and biological targeted therapies such as antibodies, small molecules (often tablets).
Dr Al-Jehani is happy to provide second opinions if requested. He works with a talented team of clinicians, pathologists and radiologists to provide the very best advice in terms of diagnosis and treatment.
Professional Memberships
MB ChB Al-Arab Medical University Libya 1989
MRCP Royal College of Physicians, London 1994
DIM RPMS University of London, London 1994
MSc in Haematology, University of London, London 1995
FRCPath Royal College of Pathologists, London 2005
CCT Postgraduate Medical Education and Training Board 2006
Academic Background
After completing his training in Medicine in 1989, he started his career in haematology at Hammersmith Hospital. In 1994 he completed his Master's degree from the University of London and attained his Specialist in Haematology status in 2006. In 2014 he was appointed as a Consultant Haematologist at Croydon University Hospital. He is currently the Clinical lead of haematology department and chair for the chemotherapy working group. Alongside his clinical work he has also has an active role in teaching doctors in training, hold appraiser role and priniciple investigator of AML19, PETrea, MCL bank and Myeloma FiTness clinical trials at Croydon University Hospital.